Efficacy of a Novel Hemostatic Powder in GI Bleeding (GRAPHE)

Nantes University Hospital (NUH)

Status: Completed

Conditions: Gastrointestinal Bleeding

Treatments: Other: Non interventional study

Study type: Observational

Funder types: Other

Identifiers

NCT02595853

RC14_0077

Details and patient eligibility

About

Hemospray™ is a new endoscopic hemostatic powder. Aims of this multicenter prospective study is to determine effectiveness of Hemospray™ on short and medium term in different clinical situations, predictive factors of rebleeding after Hemospray™ application, and feasibility of the application of hemostatic powder in routine clinical practice studying in a large sample of patients.

Enrollment: 200 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Male or female aged 18 and over who need the use of Hemospray® under their care in an emergency.
• Upper gastrointestinal hemorrhage.
• Patients who received the information note of the study and agreeing to participate (non-oral opposition gathered in the patient's medical record)

Non Inclusion Criteria:

• Patient under guardianship, curatorship.
• Pregnant woman.